VN

Vincent C. O. Njar

UB University Of Maryland, Baltimore: 19 patents #6 of 1,115Top 1%
TP Tokai Pharmaceuticals: 2 patents #2 of 8Top 25%
UM University Of Maryland: 2 patents #99 of 857Top 15%
UW University Of Washington: 2 patents #544 of 2,234Top 25%
TU Thomas Jefferson University: 1 patents #250 of 538Top 50%
US University Of Maryland Eastern Shore: 1 patents #4 of 16Top 25%
📍 Glen Burnie, MD: #1 of 214 inventorsTop 1%
🗺 Maryland: #1,036 of 35,612 inventorsTop 3%
Overall (All Time): #190,589 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12391725 Method for production of novel galeterone analogs and uses thereof Purushottamachar Puranik, Francis Murigi 2025-08-19
11707468 Methods of treating pancreatic cancer Purushottamachar Puranik, Andrew K. Kwegyir-Afful 2023-07-25
10793525 13-cis-RAMBA retinamides that degrade MNKs for treating cancer Hannah Mbatia, Vidya Ramamurthy, Senthilmurugan Ramalingam 2020-10-06
10675289 Methods of treating pancreatic cancer Puranik Purushottamachar, Andrew K. Kwegyir-Afful 2020-06-09
10617685 Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity Puranik Purushottamachar 2020-04-14
10098896 C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity Angela Brodie 2018-10-16
9884067 Androgen receptor down-regulating agents and uses thereof Lalji K. Gediya, Puranik Purushottamachar, Abhijit Godbole, Andrew K. Kwegyir-Afful, Tadas Vasaitis 2018-02-06
9808472 Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies Amina Zoubeidi, Karen Ferrante, Eva Corey, Douglas B. Jacoby 2017-11-07
9694005 Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity Puranik Purushottamachar 2017-07-04
9439912 Androgen receptor down-regulating agents and uses thereof Lalji K. Gediya, Puranik Purushottamachar, Abhijit Godbole, Andrew K. Kwegyir-Afful, Tadas Vasaitis 2016-09-13
9387216 Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies Amina Zoubeidi, Karen Ferrante, Eva Corey, Douglas B. Jacoby 2016-07-12
9295679 Prodrugs of C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity Angela Brodie, Lalji K. Gediya 2016-03-29
9156792 Retinamide and uses thereof Lalji K. Gediya, Aakanksha Khandelwal 2015-10-13
9018198 Prodrugs of C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity Angela Brodie, Lalji K. Gediya 2015-04-28
8785423 Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases Angela Brodie, Robert R. Bruno 2014-07-22
8110550 HDAC inhibitors and hormone targeted drugs for the treatment of cancer Angela Brodie, Gauri Sabnis, Lalji K. Gediya 2012-02-07
7960435 Anti-cancer agents and androgen inhibition activity compound Puranik Purushottamachar 2011-06-14
7875599 C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity Angela Brodie 2011-01-25
7265143 C-4 substituted retinoids Angela Brodie, Ivo Nnane 2007-09-04
6444683 17-azolyl steroids useful as androgen synthesis inhibitors Angela Brodie 2002-09-03
6200965 17-Azolyl steroids useful as androgren synthesis inhibitors Angela Brodie 2001-03-13
5994335 17-azolyl steroids useful as androgen synthesis inhibitors Angela Brodie 1999-11-30